BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 7787465)

  • 1. Conversion from chronic to acute coronary heart disease syndromes. Role of platelets and platelet products.
    Willerson JT
    Tex Heart Inst J; 1995; 22(1):13-9. PubMed ID: 7787465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to study the effects of platelet aggregation and thrombosis on coronary vasomotion and their clinical relevance.
    Golino P; Crea F; Willerson JT
    Ital Heart J; 2002 Apr; 3(4):220-5. PubMed ID: 12025369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of thromboxane and serotonin as mediators in the development of spontaneous alterations in coronary blood flow and neointimal proliferation in canine models with chronic coronary artery stenoses and endothelial injury.
    Willerson JT; Eidt JF; McNatt J; Yao SK; Golino P; Anderson HV; Buja LM
    J Am Coll Cardiol; 1991 May; 17(6 Suppl B):101B-110B. PubMed ID: 2016468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombocyte-vascular wall interaction and coronary heart disease].
    Lüscher TF
    Schweiz Med Wochenschr; 1991 Dec; 121(51-52):1913-22. PubMed ID: 1763300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of platelets in the pathophysiology of acute coronary syndrome.
    Massberg S; Schulz C; Gawaz M
    Semin Vasc Med; 2003 May; 3(2):147-62. PubMed ID: 15199478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanisms of acute coronary syndrome].
    Lüscher TF; Wenzel RR
    Praxis (Bern 1994); 1995 Feb; 84(6):155-64. PubMed ID: 7871298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unstable angina pectoris and the progression to acute myocardial infarction. Role of platelets and platelet-derived mediators.
    Willerson JT; Yao SK; Ferguson JJ; Anderson HV; Golino P; Buja LM
    Tex Heart Inst J; 1991; 18(4):243-7. PubMed ID: 15227406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelets and antiplatelet therapy in patients with diabetes mellitus.
    Arjomand H; Roukoz B; Surabhi SK; Cohen M
    J Invasive Cardiol; 2003 May; 15(5):264-9. PubMed ID: 12730635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications.
    Willerson JT; Golino P; Eidt J; Campbell WB; Buja LM
    Circulation; 1989 Jul; 80(1):198-205. PubMed ID: 2661053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelium dysfunction in the coronary circulation.
    Lüscher TF; Noll G
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S16-26. PubMed ID: 7700060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet drugs.
    De Meyer SF; Vanhoorelbeke K; Broos K; Salles II; Deckmyn H
    Br J Haematol; 2008 Aug; 142(4):515-28. PubMed ID: 18513285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombus formation on ruptured atherosclerotic plaques and rethrombosis on evolving thrombi.
    Badimon L; Chesebro JH; Badimon JJ
    Circulation; 1992 Dec; 86(6 Suppl):III74-85. PubMed ID: 1424053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of combined thromboxane A2 and serotonin antagonists to prevent the development of unstable angina and acute myocardial infarction.
    Willerson JT; Buja LM
    Tex Heart Inst J; 1990; 17(3):157-64. PubMed ID: 15227166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin and thrombotic complications.
    Willerson JT
    J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S13-20. PubMed ID: 1717768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the role of thromboxane A2 and serotonin in the pathogenesis of unstable angina.
    Machado AP; Saavedra JA; Ribeiro C
    Rev Port Cardiol; 1994 Dec; 13(12):935-46, 893. PubMed ID: 7873224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of PAF (platelet-activating factor) on hemostasis. Studies on endothelial cells and platelets].
    Rotllan E; Escolar G; Ordinas A; Bastida E
    Sangre (Barc); 1993 Apr; 38(2):115-9. PubMed ID: 8390724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endothelial dysfunction and coronary heart disease. Interaction of endothelium and thrombocytes].
    Vanhoutte PM
    Schweiz Rundsch Med Prax; 1993 Oct; 82(42):1161-6. PubMed ID: 8248687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Platelet physiology. Advances in platelet reactivity. Review].
    Vizcaíno-Salazar G
    Invest Clin; 1994 Mar; 35(1):41-62. PubMed ID: 8054381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endothelium in acute coronary syndromes.
    Noll G; Lüscher TF
    Eur Heart J; 1998 Apr; 19 Suppl C():C30-8. PubMed ID: 9597423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.